Industrial enzyme business Codexis Inc. lost its CEO, Alan Shaw, who quit “to pursue other interests.”
The Redwood City company (NASDAQ: CDXS) named Peter Strumph, senior vice president and head of pharmaceuticals, as interim CEO while it looks for a permanent boss. He worked 10 years at CV Therapeutics before Codexis hired him in 2010.
No comments:
Post a Comment